Human Resources

Precera Bioscience Appoints New CEO and Leadership Team

May 23, 2018

FRANKLIN, Tenn., May 17, 2018 /PRNewswire/ — Precera Bioscience, Inc. (“Precera”), formerly Sano, appointed Pamela Weir as President and Chief Executive Officer effective January 1, 2018.   Ms. Weir brings 30 years of pharmaceutical experience across diverse functions of Commercial, R&D, Operations, Business Development and General Management. She has led the development and launch of […]

DelMar Appoints Saiid Zarrabian to Full-Time President and CEO

May 23, 2018

VANCOUVER, British Columbia and MENLO PARK, Calif., May 22, 2018 /PRNewswire/ — DelMar Pharmaceuticals, Inc. (the “Company”)(NASDAQ: DMPI) today announced that the board of directors (the “Board”) has appointed Saiid Zarrabian as the full-time President and Chief Executive Officer of the Company, effective immediately. Mr. Zarrabian had previously served as the Company’s interim President and […]

Corbus Pharmaceuticals Adds Two Key Executives to Lead its Regulatory and CMC Operations

May 23, 2018

Norwood, MA (May 22, 2018) – Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) (“Corbus” or the “Company”), a Phase 3 clinical-stage pharmaceutical company focused on the development and commercialization of novel therapeutics to treat rare, chronic and serious inflammatory and fibrotic diseases, announced today the appointment of Robert Discordia, Ph.D., as Vice President, Pharmaceutical Development & […]

AnaBios Announces the Hire of Dr. Chris Mathes as Chief Commercial Officer

May 23, 2018

SAN DIEGO, May 22, 2018 /PRNewswire/ — AnaBios is pleased to announce the recent hire of Chris Mathes, Ph.D., MBA, as Chief Commercial Officer. Within this new role, Mathes will guide the company’s business development endeavors and contribute to AnaBios’ overall strategic direction as it leverages its proven drug de-risking technology based on ex vivo […]

ProSciento Appoints Pete Nieto as Vice President of Business Development

May 23, 2018

SAN DIEGO, May 23, 2018 /PRNewswire/ — ProSciento, Inc., a leading specialty clinical research organization (CRO) exclusively focused on NASH, diabetes, obesity and related metabolic diseases, today announced the appointment of Pete Nieto as Vice President of Business Development. Nieto joins ProSciento from the CRO PPD, where he served as Executive Director of Early Phase […]

Kronos Bio Appoints Dr. Norbert Bischofberger, Former Head of R&D for Gilead Sciences, as President and Chief Executive Officer and Completes $18 Million Seed Financing

May 23, 2018

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Kronos Bio, Inc. (Kronos), a Two River portfolio company, today announced the appointment of Norbert Bischofberger, Ph.D. as its President and Chief Executive Officer and completion of an $18 million seed financing. Prior to joining Kronos, Dr. Bischofberger was at Gilead Sciences for almost 30 years, where he most recently served as Executive […]

LogicBio Therapeutics Appoints Dean Falb, Ph.D., as Chief Scientific Officer

May 23, 2018

CAMBRIDGE, Mass.–(BUSINESS WIRE)–LogicBio Therapeutics, Inc., a genetic medicine company founded to develop safe and lasting treatments for children with life-threatening early onset diseases, today announced the appointment of Dean Falb, Ph.D., as chief scientific officer. Dr. Falb, who most recently served as chief technology officer at Synlogic Therapeutics, brings more than 20 years of drug […]

Exelixis Appoints Andrew R. Peters to Newly Created Position of Vice President, Strategy

May 23, 2018

SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Exelixis, Inc. (NASDAQ: EXEL) today announced the appointment of Andrew R. Peters as Vice President, Strategy. In this newly created role, Mr. Peters will work with the Exelixis leadership team to further refine the company’s mid- and long-term strategy focused on advancing the next generation of Exelixis medicines.   “Andrew’s extensive […]

Biothera Pharmaceuticals Appoints Andrew D.C. LaFrence Chief Financial Officer

May 22, 2018

EAGAN, Minn., May 16, 2018 (GLOBE NEWSWIRE) — Biothera Pharmaceuticals, Inc., announced the appointment of Andrew D.C. LaFrence, CPA as Senior Vice President and Chief Financial Officer, effective May 29.  Biothera Pharmaceuticals is a clinical stage immuno-oncology company developing a novel immunotherapy in combination with immune checkpoint inhibitors for multiple types of cancer. Mr. LaFrence […]

Liquidia Technologies Appoints Jeri Thomas as Senior Vice President, Commercial

May 22, 2018

RESEARCH TRIANGLE PARK, N.C.–(BUSINESS WIRE)–Liquidia Technologies, Inc. (“Liquidia”), a late-stage clinical biopharmaceutical company focused on improving the performance of medicine by precisely engineering drug particles, today announced the appointment of Jeri Thomas as Senior Vice President, Commercial. Ms. Thomas will have responsibility for developing and leading Liquidia’s commercial plans, with initial focus on LIQ861, an […]

Roivant Expands Senior Leadership with Key Hires

May 22, 2018

– Dr. Sam Azoulay, former SVP and Chief Medical Officer at Pfizer Essential Health, joins as Chief Medical Officer – Adele Gulfo, former President and General Manager for US Primary Care at Pfizer, joins as Chief of Commercial Development BASEL, Switzerland and NEW YORK, May 16, 2018 /PRNewswire/ — Roivant Sciences today announced the expansion […]

Corbus Pharmaceuticals Adds Two Key Executives to Lead its Regulatory and CMC Operations

May 22, 2018

— Robert Discordia, Ph.D., named Vice President, Pharmaceutical Development & Manufacturing — — Ross Lobell named Vice President, Regulatory Affairs — Norwood, MA, May 22, 2018 (GLOBE NEWSWIRE) — Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) (“Corbus” or the “Company”), a Phase 3 clinical-stage pharmaceutical company focused on the development and commercialization of novel therapeutics to […]

Human resources’ImmusanT Expands Management Team to Strengthen Financial Operations and Accelerate Clinical Development

May 21, 2018

— Kristin M. Neff joins as VP, Clinical Operations and Project Management – — Joyce A. Pinkham joins as VP, Program Management – — Jonathan Yeadon joins as Director, Finance – CAMBRIDGE, Mass.–(BUSINESS WIRE)–ImmusanT, Inc., a clinical stage company that is leveraging its Epitope-Specific Immuno-Therapy (ESIT) platform to translate and deliver first-in-class peptide-based immune therapies […]

PDL BioPharma Names Dr. Jill Jene Vice President, Business Development

May 21, 2018

INCLINE VILLAGE, Nev., May 21, 2018 /PRNewswire/ — PDL BioPharma, Inc. (“PDL” or “the Company”) (NASDAQ: PDLI) announces the appointment of Jill M. Jene, Ph.D. as Vice President, Business Development. Dr. Jene will lead the efforts to add healthcare assets to PDL’s portfolio of products and companies. She will report to PDL President, Dominique Monnet. […]

SetPoint Medical Appoints Ankit Shah to Lead Commercialization and Marketing

May 21, 2018

– Commercialization Expertise Beneficial as SetPoint Advances its Clinical Program – Valencia, CA – May 21, 2018 – SetPoint Medical, a clinical-stage biomedical technology company developing bioelectronic therapy for chronic inflammatory diseases, announced today the appointment of Ankit Shah as Senior Director of Commercialization and Marketing. Mr. Shah has more than a decade of experience […]

Recipharm and Hadasit partner to deliver seamless chemical and clinical services

May 21, 2018

Recipharm, the contract development and manufacturing organisation (CDMO), has partnered with Hadasit Medical Research Services and Development to offer combined clinical, biological and chemical services. Located in Israel, Hadasit, a wholly owned subsidiary of Hadassah Medical Organisation (HMO), offers a variety of research, development and consulting services to customers, primarily in the Middle East. With […]

Triumvira Expands Management Team with Chief Medical Officer and VP of Finance

May 18, 2018

Innovative immuno-therapy company welcomes proven leaders in pharma and therapeutics AUSTIN, Texas–(BUSINESS WIRE)–Triumvira Immunologics, a privately held biopharmaceutical company developing a novel platform for engineering T cells to attack cancers, today announced the formal appointments of Sabine Chlosta, MD, PhD, as Chief Medical Officer, and Jon Irvin as Vice President of Finance. “It’s exciting to […]

Apexigen Expands Leadership Team With Appointment Of Frances Rena Bahjat, Ph.D. Vice President, Discovery Research

May 18, 2018

    SAN CARLOS, Calif., May 18, 2018 /PRNewswire/ — Apexigen, Inc., a clinical-stage biopharmaceutical company, today announced the appointment of Frances Rena Bahjat, Ph.D. as Vice President, Discovery Research. In this newly-created position, Dr. Bahjat will report to Xiaodong Yang, M.D., Ph.D., President and Chief Executive Officer of Apexigen, and will lead the discovery […]

Roivant Expands Senior Leadership with Key Hires

May 17, 2018

  – Dr. Sam Azoulay, former SVP and Chief Medical Officer at Pfizer Essential Health, joins as Chief Medical Officer – Adele Gulfo, former President and General Manager for US Primary Care at Pfizer, joins as Chief of Commercial Development   BASEL, Switzerland and NEW YORK, May 16, 2018 /PRNewswire/ — Roivant Sciences today announced […]

Five Prime Therapeutics Appoints Bryan Irving, Ph.D., as Chief Scientific Officer

May 16, 2018

SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Five Prime Therapeutics, Inc. (Nasdaq:FPRX), a biotechnology company discovering and developing innovative immuno-oncology protein therapeutics, today announced the appointment of Bryan Irving, Ph.D., as Executive Vice President and Chief Scientific Officer. “We are delighted to promote Bryan to this important leadership role. Bryan will set forth the discovery strategy and priorities […]

Five Prime Therapeutics Appoints Bryan Irving, Ph.D., as Chief Scientific Officer

May 16, 2018

SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Five Prime Therapeutics, Inc. (Nasdaq:FPRX), a biotechnology company discovering and developing innovative immuno-oncology protein therapeutics, today announced the appointment of Bryan Irving, Ph.D., as Executive Vice President and Chief Scientific Officer.   “We are delighted to promote Bryan to this important leadership role. Bryan will set forth the discovery strategy and […]

Astellas Appoints Bernhardt Zeiher, M.D., as New Chief Medical Officer

May 16, 2018

NORTHBROOK, Ill., May 15, 2018 /PRNewswire/ — Astellas is pleased to announce that Bernhardt G. Zeiher, M.D., F.C.C.P., F.A.C.P., (“Bernie”), was promoted to Chief Medical Officer (CMO), effective April 1, 2018. Zeiher will continue serving as president of Development, while now also overseeing all other functions of Astellas’ Medical and Development (M&D) organization, including Clinical […]

EyePoint Pharmaceuticals Announces Appointment of Leonard Blum as Executive Vice President and General Manager, U.S.

May 16, 2018

WATERTOWN, Mass., May 16, 2018 (GLOBE NEWSWIRE) — EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT), a specialty biopharmaceutical company committed to developing and commercializing innovative ophthalmic products, today announced the appointment of Leonard M. Blum as Executive Vice President and General Manager, U.S., effective May 14, 2018. In this role, he will be responsible for the launch of […]

Sensei Biotherapeutics Appoints John Celebi as President and Chief Executive Officer

May 16, 2018

GAITHERSBURG, MD – May 16, 2018 – Sensei Biotherapeutics, Inc., a privately-held biopharmaceutical company developing immuno-oncology therapies that teach the immune system to recognize and attack cancer, today announced the appointment of John Celebi, M.B.A., as President and Chief Executive Officer. He also joins the company’s board of directors. Mr. Celebi brings more than two […]

Rezolute Announces Appointment of Keith Vendola as Chief Financial Officer

May 16, 2018

LOUISVILLE, Colo., May 16, 2018 (GLOBE NEWSWIRE) — Rezolute, Inc. (“Rezolute” or the “Company”) (OTCQB:RZLT), a clinical stage biopharmaceutical company specializing in the development of innovative drug therapies for metabolic and orphan diseases, announced today that Keith Vendola, M.D., M.B.A., has joined the Company as Chief Financial Officer. With two decades of expertise in healthcare […]

Complexa Appoints Francisco D. Salva Chief Executive Officer and President

May 15, 2018

BERWYN, Pa.–(BUSINESS WIRE)–Complexa Inc., a clinical stage biopharmaceutical company, today announced the appointment of Francisco D. Salva as the company’s new Chief Executive Officer and President, effective immediately. Mr. Salva has been appointed to build on the company’s progress to date by further advancing the Phase 2 clinical development of its lead compound CXA-10 in […]

UNITY Biotechnology, Inc. Appoints Camille Landis as Senior Vice President of Corporate Development

May 15, 2018

SAN FRANCISCO, May 14, 2018 (GLOBE NEWSWIRE) — UNITY Biotechnology, Inc. (“UNITY”) (NASDAQ:UBX), a biotechnology company developing therapeutics to slow, halt or reverse diseases of aging, today announced the appointment of Camille Landis as senior vice president of corporate development. “Camille brings significant experience in building and leading corporate development organizations,” said Keith Leonard, chairman […]

Rodin Therapeutics Expands Leadership Team, Adding Extensive Experience in Clinical and Business Development

May 15, 2018

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Rodin Therapeutics today announced the appointments of three senior executives with extensive experience in clinical and business development as well as a senior scientific advisor to focus on pipeline strategy. With their strong backgrounds in neuroscience, the new executives will accelerate Rodin’s progress in developing novel therapeutics to strengthen synaptic resilience in patients […]

Gt Biopharma Announces Dr. Raymond W Urbanski Elevated to President and Chief Medical Officer of the Company

May 14, 2018

LOS ANGELES, May 14, 2018 /PRNewswire/ —   GT Biopharma Inc. (OTCQB: GTBP)(Euronext Paris GTBP.PA) today announced the promotion of Dr. Raymond W Urbanski MD, PhD to the position of President and Chief Medical Officer effective immediately. Dr. Urbanski will report to Shawn Cross, the Company’s Chief Executive Officer.   “I am pleased to announce […]

TP Therapeutics Appoints Athena Countouriotis, M.D., as EVP and Chief Medical Officer

May 14, 2018

SAN DIEGO–(BUSINESS WIRE)–TP Therapeutics, Inc., a privately held, clinical-stage biopharmaceutical company developing oncology therapies with a focus on addressing current drug resistance, announced the appointment of Athena M. Countouriotis, M.D., as Executive Vice President and Chief Medical Officer.   TP Therapeutics Appoints Athena Countouriotis, M.D., as EVP and Chief Medical Officer Tweet this “The Board […]

FEEDBACK